Oncology Institute (TOIIW) Long-Term Investments (2020 - 2023)

Oncology Institute (TOIIW) has reported Long-Term Investments for 4 consecutive years, with $58.9 million the latest figure, recorded in Q2 2023.

• Long-Term Investments for Q2 2023 came in at $58.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $58.9 million (changed N/A YoY), and the FY2022 annual result was $58.4 million, changed N/A from the prior year.
• Long-Term Investments was $58.9 million for Q2 2023 at Oncology Institute, roughly flat from $58.8 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $230.3 million in Q1 2021 and troughed at $58.2 million in Q3 2022.
• Average Long-Term Investments over 4 years is $161.5 million, with a median of $230.0 million recorded in 2021.
• Year-over-year, Long-Term Investments retreated 0.05% in 2021 and plunged 74.69% in 2022.
• Over 4 years, Long-Term Investments stood at $230.3 million in 2020, then declined by 0.1% to $230.0 million in 2021, then slumped by 74.63% to $58.4 million in 2022, then grew by 1.01% to $58.9 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $58.9 million in Q2 2023, $58.8 million in Q1 2023, and $58.4 million in Q4 2022.